Cheng-ming Fei

No. 600, Yi Shan Road
Shanghai, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Research Advances on Role of Extracellular Vesicles in the Bone Marrow Microenvironment of Patients with Hematological Malignancies--Review

Research Advances on Role of Extracellular Vesicles in the Bone Marrow Microenvironment of Patients with Hematological Malignancies--Review

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 11, 2019

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.

Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes.

Journal: Journal of translational medicine

Published: June 29, 2018

Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.

Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.

Journal: Leukemia research

Published: February 17, 2017

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.

Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.

Journal: Oncotarget

Published: August 10, 2015

Osteogenic Differentiation Potential of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

Osteogenic Differentiation Potential of Bone Marrow Mesenchymal Stem Cells in Patients with Myelodysplastic Syndromes

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 29, 2015

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes.

Journal: Nature communications

Published: May 28, 2015

mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients

mRNA expression of notch ligand-delta-like-1 and jagged-1 in mesenchymal stem cells of MDS patients

Journal: Zhongguo shi yan xue ye xue za zhi

Published: December 30, 2014

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome.

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome.

Journal: Scientific reports

Published: September 17, 2014

Roles of osteoblasts in hematopoietic stem cell niche and relationship between osteoblasts and hematopoietic diseases

Roles of osteoblasts in hematopoietic stem cell niche and relationship between osteoblasts and hematopoietic diseases

Journal: Zhongguo shi yan xue ye xue za zhi

Published: August 19, 2014

Research advance of hematopoietic microenvironment for myelodysplastic syndromes

Research advance of hematopoietic microenvironment for myelodysplastic syndromes

Journal: Zhongguo shi yan xue ye xue za zhi

Published: November 02, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026